Deloitte Digital and Salesforce Join Forces to Accelerate Innovation for the BioPharma Industry

With Deloitte Digital's BioPharma industry knowledge and Salesforce technology, both companies will work together on new innovations to help pharmaceutical companies bring innovative therapies to patients faster

NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Today, Deloitte Digital and Salesforce announced plans to accelerate CRM innovation for the BioPharma industry. As this sector rapidly evolves, legacy platforms struggle to keep pace, hampering progress and innovation. Informed by Deloitte Digital's deep life sciences and health care experience serving clients around the world and Salesforce's CRM technology, the two organizations intend to develop new solutions to advance BioPharma innovation.

The BioPharma industry is undergoing rapid transformation driven by data analytics, catalyzing the creation of specialty drugs and advanced and personalized therapies that require more patient and health care provider engagement. Many BioPharma organizations rely on outdated legacy platforms ill-equipped for this shift in treatments.

Brett Davis, Deloitte's chief innovation officer, highlights the urgency of modernization, "BioPharma is experiencing groundbreaking advancements in treatments and personalized medicine. However, existing platforms, from research and development to commercial engagement, no longer align with the industry's dynamic requirements. Our collaboration with Salesforce is a commitment to pioneer the next generation of innovations that help enable the rapid scientific and technological progress of this sector."  

Deloitte and Salesforce's collaboration will empower BioPharma firms to bring innovative therapies to patients faster. In a competitive industry, speed to market is crucial. This collaboration intends to equip organizations with the tools needed to excel and impact patient outcomes positively.

"Modernizing technology in the BioPharma sector isn't just a choice; it's an imperative," said Amit Khanna, SVP and GM, health and life sciences at Salesforce. "The pace of innovation in health care is relentless, and to help accelerate the development and commercialization of new therapies, we must transform outdated systems and build new engagement models for healthcare professionals and patients across the entire value chain from clinical to commercial. This collaboration with Deloitte will help the industry achieve this transformation."

"Our deep understanding of BioPharma positions us as valuable contributors to this collaboration," said David Rosner, Deloitte Digital life sciences leader. "We're actively supporting Salesforce's product team through intellectual capital and deep global industry expertise, ensuring that solutions are finely tuned to industry-specific challenges. Our domain expertise in therapies allows us to leverage insights into therapeutic development and health care delivery, ensuring solutions are not only technologically advanced but also highly relevant globally."

The journey to revolutionize customer engagement in BioPharma has begun. Deloitte Digital and Salesforce are committed to a future where innovative technology aligns seamlessly with industry needs, benefiting patients, health care providers, and the sector as a whole. Together, Deloitte Digital and Salesforce will help propel BioPharma into a new era of success, where patients can receive the treatments and therapies, they need faster and more effectively than ever before.

Deloitte Digital returns to Dreamforce 2023, Sept. 12-14. As a Pioneer Sponsor Deloitte Digital will provide three days of hands-on learning, insightful sessions, and meaningful collaboration focused on AI + Data + CRM.      

Deloitte Digital combines consulting and creativity to solve new problems with new ideas and unlock growth across the entire customer experience. By uniting leading digital and creative capabilities with the deep industry knowledge and experience Deloitte is known for, we help clients tackle their biggest challenges. New problems are arriving faster than ever before and we're using creativity, purpose, and technology as our solution to power modern business transformation. Alongside all of Deloitte, we foster the connections necessary to shape a better future for our clients, culture, society, and the planet. Visit https://www.deloittedigital.com/us/en.html or follow Deloitte Digital on LinkedIn, Twitter, or Instagram to learn more.

Deloitte provides industry-leading audit, consulting, tax, and advisory services to many of the world's most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future.  Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte's approximately 457,000 people worldwide connect for impact at www.deloitte.com.

Salesforce and others are among the trademarks of Salesforce Inc.

Salesforce, Salesforce Einstein, Sales Cloud, Service Cloud, Marketing Cloud and others are among the trademarks of salesforce.com, inc. Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

View original content to download multimedia:https://www.prnewswire.com/news-releases/deloitte-digital-and-salesforce-join-forces-to-accelerate-innovation-for-the-biopharma-industry-301925872.html

SOURCE Deloitte Consulting LLP